SAN FRANCISCO ­– In a transaction nearly eclipsed by the bevy of pharma and big biotech deals on the opening day of the 33rd Annual J.P. Morgan Healthcare Conference, Oncore Biopharma Inc. agreed to merge with Canada's Tekmira Pharmaceuticals Corp., combining their expertise in hepatitis B virus (HBV) therapies.